Search results
AZN Obesity Pipeline to Get a Boost From Deal With China's CSPC
AstraZeneca AZN announced that it has entered into a new strategic collaboration with China-based CSPC Pharmaceutical to develop several next-generation therapies for obesity and type 2 diabetes


